PATRICK THOMPSON: Open Payments
NPI 1922772839 · WEST DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,940 in 91 payments from 21 companies in 2025. Trend: 2023 $1,185 · 2024 $1,345 · 2025 $1,940
Food & beverage: $1,877Education: $63
| Company | Payments | Amount |
|---|---|---|
| CSL Behring | 12 | $300 |
| AstraZeneca Pharmaceuticals LP | 10 | $206 |
| PFIZER INC. | 8 | $198 |
| GENZYME CORPORATION | 13 | $185 |
| Grifols USA, LLC | 6 | $146 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $139 |
| Pharming Healthcare, Inc. | 4 | $88 |
| LEO Pharma Inc. | 3 | $87 |
| Novartis Pharmaceuticals Corporation | 3 | $77 |
| Genentech USA, Inc. | 4 | $75 |
Products named: Hizentra, DUPIXENT, OCTAGAM IMMUNE GLOBULIN (HUMAN), RUCONEST, ADBRY, TEZSPIRE, Xembify, Xolair.
Industry payments across IA — which companies pay providers there.
